Understanding the Dutch Lipid Clinic Network Score (DLCNS) is imperative for healthcare professionals assessing the likelihood of Familial Hypercholesterolemia (FH), a condition characterized by dangerously high levels of cholesterol that can lead to premature cardiovascular disease (CVD). This comprehensive form functions as a critical tool by incorporating various criteria including a patient’s family history of CVD in first-degree relatives, personal history of CVD, untreated lipid levels, and physical indicators such as tendon xanthomata or arcus cornealis appearing before the age of 45. Each aspect of this information contributes to a cumulative score, which the form categorizes to gauge the probability of an FH diagnosis. These meticulous criteria ensure that the evaluation is both precise and grounded in relevant medical data, aiding in the accurate identification of individuals needing further genetic testing or specialized treatment for FH. The score ranges define the diagnosis as definite, probable, possible, or unlikely FH, thus providing a clear path for medical intervention. With Familial Hypercholesterolemia being an underdiagnosed condition, the DLCNS represents a vital resource for clinicians aiming to screen and manage patients at risk, ensuring timely and appropriate care for those impacted by this genetic disorder.
Question | Answer |
---|---|
Form Name | Dutch Lipid Score Form |
Form Length | 1 pages |
Fillable? | No |
Fillable fields | 0 |
Avg. time to fill out | 15 sec |
Other names | dutch lipid calculator, dutch lipid criteria, dutch lipid scoring, dutch lipid form |
Dutch Lipid Clinic Network Score (DLCNS) for FH
The DLCNS is a validated set of criteria based on the patients family history of premature cardiovascular disease (CVD) in their first degree relatives, their own CVD history, their untreated lipid levels and physical signs such as the presence of tendon xanthomata or arcus cornealis prior to the age of 45. The subsequent score categorizes patients by the likelihood of Familial Hypercholesterolaemia (FH) diagnosis.
|
Patient Name ___________________________ |
DOB __________________ |
Date __________________ |
||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Criteria |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
S ore |
|
Patie t S ore |
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fa |
il |
histor |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
First degree relati e |
ith k o |
pre |
ature |
oro ar a |
|
d/or |
|
|
|
|
|
|
||||||||||||||
|
|
|
|
|
|
|
|
||||||||||||||||||||
|
as ular disease |
e aged < |
ears, |
o |
e |
aged < |
|
ears |
|
|
|
|
|
|
|||||||||||||
|
OR |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
th |
|
|
|
|
|
|
First degree relati e |
ith k o |
LDL- holesterol a |
o e the |
|
|
|
|
|
||||||||||||||||||
|
|
|
|
|
|
|
|||||||||||||||||||||
|
per e tile for age a |
d ge |
der |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
First degree relati e |
ith te di ous |
a |
tho |
ata a |
d/or ar us |
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|||||||||||||||||||||
|
or |
ealis |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
OR |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
th |
|
|
|
|
|
|
|
Childre |
aged < |
|
ears |
ith LDL- |
|
holesterol a |
o e the |
|
|
|
|
|
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
|
per e tile for age a |
d ge |
der |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cli |
i |
al histor |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Patie |
ts |
ith pre |
ature |
oro |
ar |
arter |
disease |
e |
aged |
|
|
|
|
|
|
|||||||||||
|
|
|
|
|
|
|
|||||||||||||||||||||
|
|
|
|
|
|
|
|||||||||||||||||||||
|
< |
|
ears, |
o |
|
e |
aged < |
|
|
ears |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Patie |
ts |
ith pre |
ature |
ere |
ral or peripheral |
as ular |
|
|
|
|
|
|
|
|||||||||||||
|
|
|
|
|
|
|
|
||||||||||||||||||||
|
disease |
e |
aged < |
ears, |
o |
|
e |
aged < |
ears |
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ph si al e a |
i |
atio |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Te |
di |
ous |
a |
tho |
ata |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ar us |
or |
ealis |
efore |
|
ears of age |
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
I vestigatio |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LDL- |
holesterol |
|
|
ol/L |
|
|
|
|
|
|
|
|
|
|
|
|
8 |
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NB. This is the untreated LDL- |
|
|
|
|
|
. |
|
|
|
|
|
|
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
cholesterol concentration. See |
|
|
|
|
|
. |
|
|
|
|
|
|
|
|
|
|||||||||||
|
supporting documentation for |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
method of calculation. |
|
|
|
|
|
|
|
. |
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Patie |
t total |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Diag |
osis |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Defi |
ite FH |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
>8 |
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pro |
a |
le FH |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Possi |
le FH |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U likel |
FH |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
< |
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|